Pfizer

Deadlock on Indemnity Clause Keeps US Vaccines From Indian Market

Pfizer Says Its New Antiviral Pill Cuts Risk of Severe COVID by 89%

Company That Managed Pfizer Vaccine Trial Sites ‘Falsified Data’: Whistleblower

CDC Endorses COVID Booster for Millions of Older Americans, At-Risk People

India Does Not Need COVID Vaccine Booster Doses at This Stage: Experts

‘Flawed Assumptions, Lack of Critical Detail Holding up Vaccination in Rural India’

Nine Months Later, 25 Takeaways From the World’s COVID-19 Vaccination Programme